Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response.

Pharmacogenetics and genomics - 1 Sept 2013

Makowsky Robert, Wiener Howard W, Ptacek Travis S, Silva Miriam, Shendre Aditi, Edberg Jeffrey C, Portman Michael A, Shrestha Sadeep

Abstract excerpt

OBJECTIVE: Kawasaki disease (KD), response to intravenous immunoglobulin (IVIG) therapy, and associated coronary artery disease progression have been associated with genetic polymorphisms in Fc gamma receptor (FcγR) genes. However, it is not known whether the existing gene copy number (GCN) variability relates to KD treatment response, susceptibility, or associated sequelae. METHODS: The copy number of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Gene Dosage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hispanic or Latino

Share to Immunoglobulins, Intravenous

Share to Linkage Disequilibrium

Share to Mucocutaneous Lymph Node Syndrome

Share to Receptors, IgG

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 23778324
DOI: 10.1097/FPC.0b013e328363686e
PMCID: PMC4400828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response.PMID 23778324Read ↗

Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response.Semantic proximity Read ↗

FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms.Semantic proximity Read ↗

Pharmacogenomics of coronary artery response to intravenous gamma globulin in kawasaki diseaseSemantic proximity Read ↗

Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.Semantic proximity Read ↗

Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.Semantic proximity Read ↗

Pharmacogenomics of Coronary Artery Response to Intravenous Gamma Globulin in Kawasaki DiseaseSemantic proximity Read ↗

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.Semantic proximity Read ↗

Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.Semantic proximity Read ↗

Genetic Polymorphism and Intravenous Immunoglobulin Resistance Relationship in Kawasaki DiseaseSemantic proximity Read ↗

Deciphering Kawasaki disease genetics through next generation sequencing: A scoping reviewSemantic proximity Read ↗

Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.Semantic proximity Read ↗

High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.